Mount Sinai's State-of-the-Art Prostate Cancer Center Targets Quality of Life for Patients Undergoing Robotic Surgery
The resource center for prostate cancer care, led by David B. Samadi, MD, Chief of the Division of Robotics and Minimally Invasive Surgery, specializes in pre- and postsurgical care.
The Mount Sinai Medical Center has a new resource center for prostate cancer care. Led by David B. Samadi, M.D., Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology, the new state-of-the-art facility at 625 Madison Avenue in New York City specializes in pre- and post-surgery care for patients who undergo a robotic prostatectomy at Mount Sinai’s main campus. It also provides expertise in the treatment of other urologic cancers, including bladder and kidney. A multilingual staff offers assistance with patient travel arrangements, accommodations, and translation services when required.
The care that patients receive before and after undergoing robotic surgery, is as crucial to their recovery as the procedure itself, said Dr. Samadi. "At our new facility, patients are welcomed by a caring and compassionate staff who are ready to answer their questions on a variety of issues, including concerns about their continence and sexual health." The facility provides an array of learning materials and brochures, and high-definition TV screens play educational tapes, presentations and DVDs, all to put patients at ease so they are well-informed and ready to take the next step in their prostate care. "Once they undergo robotic surgery at Mount Sinai’s main campus, our new facility offers them the additional care that they need on their road to recovery."
Robotic prostatectomy, also known as Robotic Assisted Laparoscopic Prostatectomy, is a minimally invasive type of prostate cancer surgery that utilizes a laparoscopic surgical robotic unit called the da Vinci system, manufactured by Intuitive Surgical. Also known as bloodless prostate surgery, this revolutionary and advanced prostate cancer surgery profoundly reduces blood loss, pain, recovery time, trauma to surrounding tissue and the familiar unwanted side effects of other treatments. The procedure results in shortened hospital stays, faster recuperation, and the lowest possible risk of incontinence and sexual dysfunction, which sometimes are side effects of prostate cancer surgery. "Our goal," Dr. Samadi says, "is not just survival, but to improve the patient’s quality of life."
One of the nation’s leading urologic oncologists, specializing in robotics and minimally invasive surgery for prostate cancer, Dr. Samadi has treated more than 1,800 prostate cancer patients from around the world. He is one of a few urologic oncologic surgeons in the United States trained in all three primary areas of surgery - open, laparoscopic, and robotic – lending additional weight behind his advocacy for robotic surgery as the surgery of choice for prostate care.
During robotic prostatectomy, Dr. Samadi performs the procedure from a console, manipulating the hand controls and viewing the operation live through the da Vinci robot’s InSight vision system. Dr. Samadi is able to enter into the patient through a few small "keyhole" incisions and manipulate the surgical tools with some small, but precise, instruments that allow him to handle tissue with great accuracy and remove the patient's prostate gland without harm to surrounding tissue. After the procedure, the patient is left with only a few small marks on the abdomen, and without the scars that are normally associated with prostate cancer treatment and surgery.
Patients interested in obtaining more information about Mount Sinai’s new prostate cancer care facility and Robotic Assisted Laparoscopic Prostatectomy may call (212) 241-8779, (888) robot10, or visit, www.roboticoncology.com.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.
Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic-science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants.